???global.info.a_carregar???
D Ferreira is a cancer researcher and member of the Portuguese Society of Human Genetics (Sociedade Portuguesa de Genética Humana - SPGH), with a keen interest in the application of new technologies to healthcare and biological sciences and in multidisciplinary R&D projects. Throughout his career, D Ferreira has participated in 11 research projects and counts 2+ years of international experience. After a brief stint in the neurosciences field, he has focused his efforts in the study of several cancers, with a particular focus in cancers of the digestive system. D Ferreira has a degree in Biochemistry by the University of Porto and a master degree in Biology, where he has studied multiple aspects of Hodgkin´s lymphoma. D Ferreira concluded recently a PhD degree in Molecular and Cellular Biotechnology Applied to Health Sciences (BiotechHealth). Throughout his PhD studies, D Ferreira, specialized in biotechnology, materials science and tissue engineering, with a particular focus in the development of organ-on-a-chip platforms, a work that generated several first-author publications, as well as a patent. In 2016, D Ferreira concluded successfully a post-graduation in Intelectual Property by the World Intelectual Property Organization (WIPO). D Ferreira has published 11 peer reviewed articles in international journals, as well as 4 abstracts in conference proceedings, a book chapter and a patent on a microfabrication technique, for complex multilayered organ-on-a-chip devices with integrated microactuators. D Ferreira has an h-index of 10, having been cited 209 times (source: Scopus - Author ID 55927177600) and has presented his work multiple times in international and national conferences through poster and oral presentations. D Ferreira currently holds a post-doc researcher position at i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Associação where he is the principal investigator of 2 research projects, having secured over 80.000 euros of funding, in his first year as a post-doc. Since then he has gained a further 136.000 euros divided by 3 complementary projects which will fund his research until the end of 2026. D Ferreira was distinguished at the 12th International Meeting of the Portuguese Society for Stem Cells and Cellular Therapy with a best oral communication award and also with the International 3Rs prize awarded by the National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs, UK). Recently we won the 2023 European Society of Human Genetics Fellowship of Excellence and the Best Clinical Research Award at the 27th Annual SPGH conference. His patented technology was also an honorable mention at the 2022 Lush Prize awards (finalist for the Science Category) and top 3 finalist at the 2022 Altice International Innovation Awards. In 2023 he was an honorable mention for the Alfredo da Silva Awards in the Sustainability in Health Category, His awards also include a prestigious short-term EMBO fellowship. International recognition has garnered D Ferreira several invitations to teach at Advanced Course Units in several Portuguese Universities, as well as speaker invitations at international meetings and an invitation to join the scientific commitee for the PhDay Conference at i3S and was a member of the organizing committee of the 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting held in June 2024, Porto, Portugal. International recognition has earned D Ferreira an invitation to participate in the preparation and submission of a COST Action on Advanced Microfluidics for Applied Diagnostics in 2022 and integrated a Twinning- Bottom Up application in 2023. D Ferreira is an invited reviewer for the journals, Bioprinting, Organoids and Cancers. D Ferreira has supported and supervised several traineeship and master students. D Ferreira is a member of the team that created and manages the first Portuguese 3Rs Knowledge Center and i3S' Startup Hub.
Read full resume ↓
Identification

Personal identification

Full name
Daniel André Gonçalves Ferreira

Citation names

  • Ferreira, Daniel A.

Author identifiers

Ciência ID
D61E-C674-D0F4
ORCID iD
0000-0002-9712-1460
Researcher Id
AAK-4154-2020
Scopus Author Id
55927177600

Email addresses

  • daniel.ferreira@i3s.up.pt (Professional)

Telephones

Telephone
  • (00351) 226 074 90 (Professional)

Addresses

  • R. Alfredo Allen 208, 4200-135, Porto, Porto, Portugal (Professional)

Websites

Knowledge fields

  • Natural sciences - Biological Sciences - Biochemistry
  • Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology
  • Natural sciences - Biological Sciences - Molecular Biology
  • Medical and Health Sciences - Medical Biotechnology - Technologies Involving the Manipulation of Cells, Tissues, Organs or the Whole Organism

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Spanish; Castilian Intermediate (B1) Advanced (C1) Intermediate (B1) Proficiency (C2) Intermediate (B1)
Education
Degree Classification
2021/12/14
Concluded
 International Doctoral Programme in Molecular and Cellular Biotechnology Applied to Health Sciences (Doutoramento)
Major in Microfluídics and organ-on-a-chip platforms. Genetics of Cancer, Gastric Cancer
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"A tissue engineering approach to fabricate a stomach-on-a-chip: a biomimetic device to decode the role of CD44v6 in gastric cancer" (THESIS/DISSERTATION)
 Aprovado por unanimidade
2016/10 - 2016/11
Concluded
 General Course on Intellectual Property (Pós-Graduação)
Major in Intelectual Property
World Intelectual Property Organization, Switzerland
2009/12/22
Concluded
 Biology (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
"Optimization of cell cycle synchronization and transfection protocols in a Hodgkin's Lymphoma derived human cell line." (THESIS/DISSERTATION)
 17
2004/11/29
Concluded
 Biochemistry (Licenciatura)
Major in Bioquímica Aplicada
Universidade do Porto Faculdade de Ciências, Portugal
"Role and regulation of phosphoERKs activity in vesical function under different conditions." (THESIS/DISSERTATION)
 13
Affiliation

Science

Category
Host institution 		Employer
2022 - Current Postdoc (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2012 - 2021 Researcher (Research) Instituto Nacional de Engenharia Biomédica, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal
2017/09/15 - 2018/03/31 Visiting Researcher (Research) Instituto Nacional de Engenharia Biomédica, Portugal
Technische Universität Wien Fakultät für Technische Chemie, Austria
2016 - 2016 Visiting Researcher (Research) Instituto Nacional de Engenharia Biomédica, Portugal
INESC Microsistemas e Nanotecnologias, Portugal
2015 - 2015 Visiting Researcher (Research) Instituto Nacional de Engenharia Biomédica, Portugal
INESC Microsistemas e Nanotecnologias, Portugal
2008 - 2012 Researcher (Research) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2011/01/01 - 2011/04/30 Visiting Researcher (Research) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
VU Medisch Centrum, Netherlands
2006 - 2008 Researcher (Research) Leids Universitair Medisch Centrum, Netherlands
Leids Universitair Medisch Centrum, Netherlands
2005 - 2006 Researcher (Research) Instituto Gulbenkian de Ciência, Portugal
Instituto Gulbenkian de Ciência, Portugal
Projects

Grant

Designation Funders
2014 - 2021 A tissue engineering approach to fabricate a stomach-on-a-chip: a biomimetic device to decode the role of CD44v6 in gastric cancer
PD/BD/105976/2014
PhD Student Fellow
Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2013 - 2014 TUMORTAG - Tumor-targeted nanoparticles for early diagnosis of gastric cancer
PTDC/CTM-NAN/120958/2010
Research Fellow
Fundação para a Ciência e a Tecnologia
Concluded
2011 - 2013 Exploring the role of E-Cadherin-HER interaction in the search of molecular biomarkers for the clinical management of gastric cancer patients
PIC/IC/82923/2007
Other
VU Medisch Centrum, Netherlands
Concluded
2011/01 - 2011/03 Systematic analysis of novel and previously characterized E-cadherin expression repressors/modulators in gastric cancer
ASTF number 466-2010
Researcher
Amsterdam UMC Locatie VUmc Instituut voor onderwijs en opleiden, Netherlands
 European Molecular Biology Organization (EMBO)
2009 - 2011 Role of novel regulatory mechanisms in the loss of E-cadherin expression
PTDC/SAU-GMG/72168/2006
Master Student Fellow
Fundação para a Ciência e a Tecnologia
Concluded
2006 - 2008 Prevention, detection and molecular characterisation of mismatch repair-related hereditary cancers of the digestive system
FP6-018754
Research Fellow
Leids Universitair Medisch Centrum, Netherlands
 European Commission Sixth Framework Programme
Concluded
2005 - 2006 Study of the function of A Kinase Anchoring Proteins (AKAPs) on the regulation of synaptic activity
POCTI/BIA-BCM/56938/2004
Research Fellow
Associação para a Inovação e Desenvolvimento da FCT
Concluded

Contract

Designation Funders
2024/12/31 - Current Concurso NCH-PT 2024 | Projeto HDCHIP (N. Ref. NCH2024005)
NCH2024005
Principal investigator
2024/12/01 - Current Caixa Impulse Innovation 2024 - Stage 1 Project
CI24-10293
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023/01 - Current Disclosing the genesis of hereditary stomach cancer through organ-on-a-chip technology
2022.02951.PTDC
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2023 - Current PREVENTABLE - Sustainable care for rare tumor risk syndromes
Project number 101095483
Post-doc
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Ongoing
2023/01 - 2023/12 3Rs international Prize Award - £28000 total funding
N/A
Principal investigator
National Centre for the Replacement Refinement and Reduction of Animals in Research
Ongoing
2021 - 2023 Life-time Risk Estimations and Genetic Modifiers Of Hereditary Diffuse Gastric Cancer (LEGOH)
PTDC/BTM-TEC/6706/2020
Post-doc
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
Outputs

Publications

Book chapter
  1. Tiago dos Santos; Ferreira, Daniel A.; Pedro L. Granja. "Chapter3.2 - Cell-based in vitro models for gastric permeability studies". In Concepts and models for drug permeability studies. Woodhead Publishing, 2023.
    Published
Conference abstract
  1. Ferreira, Daniel. "PO-501 Deconstructing the role of cd44 in gastric cancer resistance to cisplatin". 2018.
    10.1136/esmoopen-2018-eacr25.518
  2. Ferreira, Daniel. "Abstract 1611: Epithelial-mesenchymal-epithelial transition induced by long term exposure to TGFB1 creates cellular heterogeneity". 2016.
    10.1158/1538-7445.am2016-1611
Conference paper
  1. Daniel A. Ferreira; João P. Conde; Peter Ertl; Carla Oliveira; Pedro L. Granja. "Proceedings of the 25th Annual Meeting of the Portuguese Society of Human Genetics (SPGH – Sociedade Portuguesa de Genética Humana)". 2021.
    10.1097/md.0000000000029313
Conference poster
  1. Ferreira, Daniel A.. "A novel biomimetic tool to study disease initiation of deadly Hereditary Diffuse Gastric Cancer syndrome". Paper presented in PREVENTABLE Mid-Term Conference, 2024.
  2. Daniel A. Ferreira. "A novel biomimetic tool to study disease initiation of deadly Hereditary Diffuse Gastric Cancer syndrome". Paper presented in IV INTERNATIONAL MEETING OF THE PORTUGUESE SOCIETY OF GENETICS, 2023.
  3. Ferreira, Daniel. "A bioinspired human stomach-on-a-chip to study gastric cancer initiation". Paper presented in 28th Porto Cancer Meeting, 2022.
  4. Ferreira, Daniel. "Fabrication of a human stomach-on-a-chip device displaying organ-like features". Paper presented in 25th Annual Meeting of the SPGH, 2021.
  5. Ferreira, Daniel. "A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators". Paper presented in 31st Conference of the European Society for Biomaterials (ESB2021) together with 43rd Annual Congress of the Iberian Society of Biomechanics and Biomaterials (SIBB), 2021.
  6. Ferreira, Daniel. "CD44v6 in gastric cancer, a marker of progression or a culprit?". Paper presented in 5th Advanced Summer School: Interrogations at the Biointerface – the nano/medicine interface, 2016.
Journal article
  1. Daniel A. Ferreira; João P. Conde; Mario Rothbauer; Peter Ertl; Pedro L. Granja; Carla Oliveira. "Bioinspired human stomach-on-a-chip with in vivo like function and architecture". Lab on a Chip (2023): https://doi.org/10.1039/D2LC01132H.
    10.1039/D2LC01132H
  2. Mafalda Santos; Marta Ferreira; Patrícia Oliveira; Nuno Mendes; Ana André; André F. Vieira; Joana B. Nunes; et al. "Epithelial-Mesenchymal Plasticity Induced by Discontinuous Exposure to TGFß1 Promotes Tumour Growth". Biology (2022): https://www.mdpi.com/2079-7737/11/7/1046.
    10.3390/biology11071046
  3. Daniel A. Ferreira; Mario Rothbauer; João P. Conde; Peter Ertl; Carla Oliveira; Pedro L. Granja. "A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators". Advanced Science (2021): https://doi.org/10.1002/advs.202003273.
    10.1002/advs.202003273
  4. Ferreira, Daniel. "Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells". Cancers (2020): http://dx.doi.org/10.3390/cancers12040858.
    10.3390/cancers12040858
  5. Ferreira, Daniel. "Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles". European Journal of Pharmaceutics and Biopharmaceutics 127 (2018): 366-370. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043984392&doi=10.1016%2fj.ejpb.2018.03.005&partnerID=40&md5=16637db821f292c61e9e4a81024ad38a.
    10.1016/j.ejpb.2018.03.005
  6. Ferreira, Daniel. "Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6". Acta Biomaterialia 81 (2018): 208-218. http://www.sciencedirect.com/science/article/pii/S1742706118305725.
    https://doi.org/10.1016/j.actbio.2018.09.043
  7. Bianca N. Lourenço; Nora L. Springer; Daniel Ferreira; Carla Oliveira; Pedro L. Granja; Claudia Fischbach. "CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling". Integrative Biology 10 3 (2018): 145-158. https://doi.org/10.1039/C7IB00179G.
    10.1039/C7IB00179G
  8. Oliveira, Patricia; Carvalho, Joana; Rocha, Sara; Azevedo, Mafalda; Vieira, Andre F.; Ferreira, Daniel; Mendes, Nuno; et al. "Epithelial-mesenchymal-epithelial transition induced by long term exposure to TGFB1 creates cellular heterogeneity". Cancer Research (2016): https://publons.com/publon/7147057/.
    10.1158/1538-7445.AM2016-1611
  9. Bordeira-Carriço, R.; Ferreira, D.; Mateus, D.D.; Pinheiro, H.; Pêgo, A.P.; Santos, M.A.S.; Oliveira, C.. "Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA". European Journal of Human Genetics 22 9 (2014): 1085-1092. http://www.scopus.com/inward/record.url?eid=2-s2.0-84906269658&partnerID=MN8TOARS.
    10.1038/ejhg.2013.292
  10. Drost, M.; Lützen, A.; Van Hees, S.; Ferreira, D.; Calléja, F.; Zonneveld, J.B.M.; Nielsen, F.C.; Rasmussen, L.J.; De Wind, N.. "Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome". Proceedings of the National Academy of Sciences of the United States of America 110 23 (2013): 9403-9408. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878715707&partnerID=MN8TOARS.
    10.1073/pnas.1220537110
  11. Pinheiro, H.; Carvalho, J.; Oliveira, P.; Ferreira, D.; Pinto, M.T.; Osoquot;rio, H.; Licastro, D.; et al. "Transcription initiation arising from E-cadherin/CDH1 intron2: A novel protein isoform that increases gastric cancer cell invasion and angiogenesis". Human Molecular Genetics 21 19 (2012): 4253-4269. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866408689&partnerID=MN8TOARS.
    10.1093/hmg/dds248
  12. Cruz, C.D.; Ferreira, D.; Mcmahon, S.B.; Cruz, F.. "The activation of the ERK pathway contributes to the spinal c-fos expression observed after noxious bladder stimulation". Somatosensory and Motor Research 24 1-2 (2007): 15-20. http://www.scopus.com/inward/record.url?eid=2-s2.0-34547865090&partnerID=MN8TOARS.
    10.1080/08990220601143265
  13. Cruz, CD; Ferreira, D; McMahon, SB; Cruz, F. "Phosphorylation of extracellular signal regulated kinases (ERK) in the spinal cord depends on vanilloid-insensitive primary afferents as shown by intravesical instillation of resiniferatoxin". The FEBS Journal (2005): https://publons.com/publon/28317163/.

Intellectual property

Patent
  1. Ferreira, Daniel. 2022. "Fabrication of microactuator and in-line degasser in organ-on-a-chip devices and methods thereof".
    Granted/Issued

Other

Other output
  1. CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients. 2018. Carla Pereira; Daniel Ferreira; Carolina Lemos; Diana Martins; Nuno Mendes; Daniela Almeida; Pedro Granja; et al. https://doi.org/10.1101/468934.
    10.1101/468934
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/06/15 A novel model for early cancer detection in Hereditary Diffuse Gastric Cancer 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting
i3S - Instituto de Investigação e Inovação em Saúde (Porto, Portugal)
2024/06/14 In vitro, in vivo and in silico models of HDGC 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting
i3S - Instituto de Investigação e Inovação em Saúde (Portugal)
2023/11 AN INSIGHT ON THE ORIGINS OF HEREDITARY DIFFUSE GASTRIC CANCER THROUGH ORGANOID DRIVEN ORGAN-ON-A-CHIP TECHNOLOGY 27th Annual SPGH Meeting, Lisbon, Portugal
(Lisbon, Portugal)
2023/04 Chipping away at animal models - Novel fabrication methodology for organ-on-a-chip devices, towards better personalized medicine and reducing impact on animal based research Remodel Conference
i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto (Porto, Portugal)
2023 HDGC-on-a-chip. Merging patient-derived iPSCs and microfluidics to disclose the genesis of Hereditary Diffuse Gastric Cancer i3S Post-doc Seminars
i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto
2023 Merging patient-derived iPSCs and organ-on-a-chip technology to disclose the genesis of Hereditary Diffuse Gastric Cancer 2023 European Society of Human Genetics Conference
European Society of Human Genetics (Glasgow, United Kingdom)
2022/10 Open access organ-on-a-chip technology for life-sciences PIPE-CF & UK CF Infection Biorepository Joint workshop
PIPE-CF & UK CF (Liverpool, United Kingdom)
2022/03 Human stomach-on-a-chip device displaying organ-like features 12th International Meeting of the SPCE-TC
2022 Bioinspired human stomach-on-chip with in-vivo like function and architecture i3S Post-doc Seminars
i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto (Portugal)
2022 A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators International 3Rs prize award event
(United Kingdom)
2021/05 Órgão-em-chip como alternativa à experimentação animal VI Jornadas de Bioquímica - "O Passaporte para a Inovação"
Faculdade de Ciências da Universidade do Porto (Portugal)
2016 CD44v6 in gastric cancer, a marker of progression or a culprit? 5th Advanced Summer School: Interrogations at the Biointerface – the nano/medicine interface
Instituto Nacional de Engenharia (Porto, Portugal)
2012 Systematic analysis of novel and previously characterized E-cadherin expression repressors/modulators in gastric cancer Third I3S Scientific Retreat
(Póvoa do Varzim, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2024/09 - Current Early detection of Diffuse Gastric Cancer in Hereditary Diffuse Gastric Cancer
Supervisor
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2024 - 2024 Development of an organ-on-a-chip platform to study Hereditary Diffuse Gastric Cancer syndrome
Supervisor
 PROJETO INTEGRADOR EM BIOENGENHARIA MOLECULAR (Degree)
Universidade do Porto Faculdade de Engenharia, Portugal
2023 - 2024 A biomarker-based model for early cancer detection in Hereditary Diffuse Gastric Cancer
Supervisor
 Biologia Celular e Molecular (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2022/09 - 2023/07 Development of an in-vitro biomimetic model of HDGC
Supervisor
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2024/10 - Current 3R Day - Models in Biomedical Research Conference (2024)
Conference (Member of the Organising Committee)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2024/06 - Current 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting (2024/06)
Conference (Member of the Organising Committee)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2016 - Current Organizer of PenguinCon, a social event conference aimed at boardgames and miniatures games enthusiasts. (2016)
Festival (President of the Organising Committee)
2015 - Current Member of the organizing comittee for the 2nd Annual Biotechhealth Symposium - Biotechnology Towards Medicine. (2015)
Conference (Member of the Organising Committee)

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2024/05/09 Advanced microfluidic devices for cell culture and point-of-care immunoassays
(Thesis) Main arguer
 Pedro Gabriel Condelipes Monteiro (PhD)
Universidade de Lisboa Instituto Superior Técnico, Portugal

Association member

Society Organization name Role
2021 - Current Portuguese Society of Human Genetics (Sociedade Portuguesa de Genética Humana - SPGH)

Committee member

Activity description
Role 		Institution / Organization
2023/04 - Current Committee member involved in the creation and management of the first 3R Knowledge Center in Portugal. This infrasctucture is a centralized knowledge hub for the 3Rs principles in animal research (replacement, reduction and refinement) - https://3rknowledge.i3s.up.pt/
Member
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Conference scientific committee

Conference name Conference host
2022 - 2022 PhDay: Building Paths: The science behind us i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto

Consulting

Activity description Institution / Organization
2018 - 2018 Invited evaluator at the Agência de Avaliação e Acreditação do Ensino Superior (A3ES). Served as an evaluator in the process of accrediation of higher degree courses (Scientific area of Biological Sciences) in 2018.
2016 - 2016 Invited evaluator at the Agência de Avaliação e Acreditação do Ensino Superior (A3ES). Served as an evaluator in the process of accrediation of higher degree courses (Scientific area of Biological Sciences) in 2016.

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2023/05 - Current Background, genetics and pathology of gastric cancer (Doutoramento)
2023 - Current Advanced Cell culture techniques: from basic cell biology to Bioengineering (Doutoramento) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2023/03 - 2023/03 Modeling the gastric environment - From 2D to advanced 3D models Advanced In Vitro modeling approaches (Pós-Graduação) Universidade do Minho Escola de Ciências da Saúde, Portugal
2019 - 2019 Tackling the gastric barrier: concepts, models and challenges In vitro models of biological barriers for Health Sciences Applications (Doutoramento) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Universidade do Porto Faculdade de Farmácia, Portugal

Interview (newspaper / magazine)

Activity description Newspaper / Forum
2023 Editor's Choice: «Alternative to soft lithography for the production of elastomer-based organ-on-chip devices with micro-actuators», by Daniel Ferreira, Carla Oliveira and Pedro Granja i3S Newsletter - Editor's choice column
2023 SPGH premeia investigação do i3S em Cancro Gástrico Difuso Hereditário
2023 SPGH awards Best Clinical Research Work to i3S project on Hereditary DIffuse Gastric Cancer
2022 Técnica alternativa à experimentação animal vale prémio internacional ao i3S https://shorturl.at/otvI9 Notícias U Porto
2022 Investigador do i3S premiado por produzir um estômago-em-chip Notícias U Porto
2022 Sampedrense premiado por desenvolver um estômago-em-chip Vivacidade
2021 Interview for national Magazine, Visão - Nova técnica permite criar em pouco tempo e baixo custo um órgão-em-chip Visão
2021 Nova tecnologia desenvolvida em parceria com investigadores do iST e da TU Wien permite fabricar um órgão-em-chip em poucas horas Notícias U Porto
2021 Investigadores do Porto criam técnica alternativa à experimentação em animais Website - Porto's City Hall
2021 Cientistas portugueses encontram alternativas para substituir experimentação animal WELECTRIC - Portuguese technology news outlet
Distinctions

Award

2024 Prémio FAZ Ciência 2024 - Honorable Mention - Top 3
2023 European Society of Human Genetics Fellowship of Excellence
European Society of Human Genetics, Austria
2023 Best Clinical Research Award - 27th Annual SPGH Conference, Lisbon, Portugal
Sociedade Portuguesa de Genética Humana, Portugal
2023 Honorable Mention at the 2023 Alfredo da Silva Awards - Sustainability in Science Category
2022 Best oral presentation - 12th International Meeting of the Portuguese Society for Stem Cells and Cell therapies
Sociedade Portuguesa de Células Estaminais e Terapia Celular, Portugal
2022 International 3Rs prize
National Centre for the Replacement Refinement and Reduction of Animals in Research, United Kingdom
2022 Finalist (top 3) - Altice International Innovation Awards 2022 - PhD thesis category
Altice Labs, Portugal
2022 Finalist in the Science Category - Lush Prize 2022 - Science Category
Flushing Area Library, United States
2011 EMBO short term Fellowship Award
European Molecular Biology Organization (EMBO), Germany